Skip to main content

Table 2 Demographic and laboratory data of patients with and without dyslipidemia

From: Prevalence and pattern of dyslipidemia in an Egyptian children and adolescents with type 1 diabetes

  Dyslipidemia (n = 568) Normo-lipidemia (n = 238) P value
Age (years), median (range) 12.1 (2.6–18) 12 (3–17.7) 0.29
Sex
• Male 243 (42.78%) 115 (48.32 %) 0.15
• Female 325 (57.22 %) 123 (51.68 %)
Age of diabetes onset (years), median (range) 6.1 (1–15) 6 (1–15.1) 0.75
Diabetes duration (years), median (range) 5 (1–17) 5 (1–15) 0.08
Insulin dose (U/kg/day), mean ± SD 1.1 ± 0.7 1.2 ± 0.67 0.06
Weight SDS, mean ± SD − 0.7 ± 1.4 − 0.89 ± 1.3 0.07
Height SDS, mean ± SD − 1.53 ± 1.6 − 1.62 ± 1.4 0.45
BMI SDS, mean ± SD − 0.56 ± 1 − 0.7 ± 1.2 0.08
TC (mg/dl), mean ± SD 167.96 ± 75.8 128.75 ± 29.71 < 0.001*
TG (mg/dl), mean ± SD 90.24 ± 41.42 68.5 ± 23.25 < 0.001*
LDL (mg/dl), mean ± SD 107.69 ± 31.81 73.94 ± 16.87 < 0.001*
HDL (mg/dl), mean ± SD 48.59 ± 18.45 59.53 ± 15.1 < 0.001*
HbA1c (%), mean ± SD 8.79 ± 1.77 8.62 ± 1.83 0.22
Glycemic control
 Poor 425 167 0.17
 Good 143 71
  1. *P value < 0.05 is considered significant, TC total cholesterol, TG triglycerides, LDL low-density lipoprotein, HDL high-density lipoprotein, HbA1c glycosylated hemoglobin, BMI body mass index, SDS standard deviation score